Obesity Clinical Trial
Official title:
Effectiveness of 5-Hydroxytryptophan on Satiety in a Randomised, Placebo Controlled, Time Blinded Study, in Overweight Women
The aim of the study is to show evidence of the efficacy of 5-HTP to induce satiety and to
reduce food intake (confirmatory study).
The primary objective of the present study is to determine:
- the effectiveness of a 5-HTP preparation on satiety markers (before intake of a meal
and during the day)
The secondary objectives of the present study are to determine the effectiveness of a 5-HTP
preparation on:
- food consumption (amount and composition) during a free meal (dinner);
- wellness after one week supplementation;
- the intermeal interval;
- body weight and waist-hip ratio (WHR).
One of the physiological factors regulating the food intake pattern is satiety. Satiety is
defined as the absence of ingestive motivation, which ends when the next meal is initiated
(Blundell et al., 1996). Food intake affects a number of physiological objective parameters
in blood known to be involved in signalling satiety, such as glucose (Melanson et al, 1999;
Chapman et al, 1999; Campfield et al, 1996), insulin (Speechly et al, 2000) and
cholecystokinin (CCK) (Gutzwiller et al., 2000; Beglinger et al., 2001; French et al., 2000;
Degen et al., 2001; Burton-Freeman et al., 2002, 2004). More recently, the gastric hormone
ghrelin was identified as a marker for hunger and meal initiation (De Graaf et al., 2004).
Humans do not only eat in response to a metabolic or physiological need. Humans also respond
to a significant extent to other internal subjective and emotional signals (clues). The
exact relations between the physiological internal signals and subjective and emotional
internal signals are not known. Besides also external and social factors modulate
physiological-derived hunger and satiety signals.
Though the regulation of food intake has been studied quite extensively, the underlying
mechanism is not elucidated yet and still new factors involved in this regulation are being
found. It is known that the macronutrients such as lipids, proteins and carbohydrates affect
satiety differently, but this mechanism is still not very clear either.
Nowadays, more and more food supplements become available suggesting to affect hunger and
satiety sensations, resulting in the long-term in weight loss. For example dietary fibres
are known for their satiating effect.
The food supplement 5-HTP is used for this purpose as well. The food supplement, already
available in the United States and in Italy, has been investigated for multiple indications
such as migraine, depression, anxiety, fibromyalgia, hypertension, insomnia and obesity.
Different clinical studies have been performed with 5-HTP for more than three decades now.
With respect to lowering of food intake, 5-HTP has been studied as well.
5-HTP is an amino acid produced by the human body from the essential amino acid
L-tryptophan, which is found in food products. Its clinical value is the ability to increase
production of serotonin. As a potentially valuable supplement it has been used clinically
for more than 30 years. 5-HTP occurs naturally in two places – the human body and the seeds
of the Griffonia simplicifolia, a West African medicinal plant.
5-HTP is the amino acid precursor of serotonin. Normal levels of serotonin are important for
emotional well-being, may play a role in appetite suppression, and decreased carbohydrate
and fat intake. Only free plasma tryptophan can cross the blood brain barrier via a carrier
protein to enter the central nervous system (CNS). Once in the CNS, tryptophan is converted
to 5-HTP and then is decarboxylated to serotonin. The levels, and possible function, of
several neurotransmitters can be influenced by the supply of their dietary products. A
reduction in tryptophan has been correlated to a reduction in serotonin (Curcio et al.,
2005).
The 5-HTP metabolism is then influenced by plasma tryptophan levels, which are related to
food intake. Serotonin synthesis is directly dependent on the availability of the specific
precursor tryptophan and on the nutritional status.
The effect of 5-HTP intake on food intake and mood is based on the serotonin production.
Numerous studies have shown that long-term consumption of 5-HTP (levels up to 900 mg daily)
reduced food intake and resulted in weight loss.
In a previous study by Laboratoire Oenobiol with moderately overweight men aged 20-40 years,
given 50 or 150 mg 5-HTP half an hour before lunch and half an hour before dinner, a reduced
energy intake with 300 mg 5-HTP compared to placebo was found. This was supplied acutely on
one day.
The study reported a linear dose related effect, with significant food intake inhibition
effect with a 300 mg/day 5-HTP dose. The dose of 100 mg/day did not produce statistically
significant effects compared to placebo. However, 100 mg of 5-HTP could prove to be
sufficient if given under chronic administration conditions.
In the present study therefore subjects will be supplied with 100 mg 5-HTP daily for one
week. Hunger and satiety feelings, food intake and wellness will be investigated. The study
will be conducted with overweight women, assuming that this group of subjects will be the
target group.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double-Blind, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |